As we know more about how these cells participate in the control of food intake, the discovery of new therapeutical approaches to metabolic diseases, such as diabetes, obesity, or leptin resistance, looks increasingly plausible. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.